Aug 2026· Talanta: The International Journal of Pure and Applied Analytical Chemistry· Vol 312 Pt B, pp.
130520
· 0 citations· 47 references
Medicine
TL;DR
A gate-array-based OFET biosensor that improves detection sensitivity, stability, and analytical throughput and introduces a robust platform for high-throughput, multi-target detection in complex biological environments, advancing next-generation biomedical diagnostics and personalized healthcare.
Abstract
Real-time, high-sensitivity biosensors are essential for personalized healthcare, enabling early disease diagnosis and continuous monitoring. Organic field-effect transistor (OFET) sensors offer label-free detection, rapid response, and low cost, but noise interference and inherent architectural limitations hinder their use in high-throughput, multi-signal analysis. To address these issues, this study presents a gate-array-based OFET biosensor that improves detection sensitivity, stability, and analytical throughput. The integrated gate-array architecture and signal modulation strategies enable rapid acquisition of multiple transfer curves for efficient concentration analysis of unknown samples. To validate the approach, the sensor detects the thrombotic biomarker D-Dimer with an ultra-low limit of 0.354 ng/mL in PBS, well below clinical thresholds, and performs reliably in human serum and patient samples. This work introduces a robust platform for high-throughput, multi-target detection in complex biological environments, advancing next-generation biomedical diagnostics and personalized healthcare.
Integrating multiple bioanalytical functions onto a single chip for point-of-care protein detection remains challenging. Here, we introduce a biological detection system-on-chip (BDSoC) that merges the purification capabilities of microfluidic chips with the detection sensitivity of carbon nanotube (CNT) field-effect t...
Zi-Jun Zhao, Lu Wan, Ke-Min Wang et al.· ACS Sensors· 0 citations
Accessible molecular diagnostics is fundamental to effective healthcare. While most current point-of-care devices detect only the presence of a molecular biomarker(s), biomarker quantification can be equally important for decision-making on disease treatment and containment. Here, we present a diagnostic platform that...
Accurate and precise quantification of trace-level cytokines in complex biological matrices remains challenging, limiting their use as longitudinal biomarkers in clinical studies. Here, we present a nanotechnology-enabled surface-enhanced Raman scattering (SERS) platform incorporating an internal standard (IS) for di...
Yi-Wen Zhang, Fahimeh Farokhinejad, Jacob J. Crouse et al.· Analytical Chemistry· 0 citations
A matrix-oriented framework for assessing the translational potential of nanomaterial-enabled anti-doping sensors is defined, linking material design, sensing format, matrix-specific validation, and practical deployment requirements.
Shaoquan Chu, Qiyuan Jing· Analytical and Bioanalytical...· 0 citations
Electrochemiluminescence immunoassay (ECLIA) is a powerful analytical method for protein biomarker detection, and plays a critical role in early disease diagnosis and clinical monitoring. However, conventional ECLIA is limited by poor multiplexing capacity, typically allowing only single-target measurement per run. H...
Wei-Yu Qu, Chun-Yan Liu, Li Shen et al.· Analytical Chemistry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.